Delivery Order SPE2DB24D2013-SPE2DB26FCGPQ
- Not listed
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 80 mg capsules (30-count units) valued at $2,118.65. This competitive, non-set-aside award, issued on September 16, 2025, represents a firm fixed price delivery order with an ultimate completion date of September 17, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office....
- The Defense Logistics Agency awarded a delivery order valued at $1,404.09 to AmerisourceBergen Drug Corp for Carvedilol ER 20 mg capsules (30-count units) on August 26, 2025, with an ultimate completion date of August 27, 2025. This firm fixed price, non-set-aside contract will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count units) under a firm fixed-price contract valued at $6,954.24. This is a non-set-aside competitive award with an ultimate completion date of September 30, 2025, with performance taking place at the vendor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $1,872.12 delivery order to AmerisourceBergen Drug Corp for Carvedilol ER 20 mg capsules (30-count units) on September 2, 2025, with a completion date of September 3, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen Drug Corp...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Carvedilol ER 40 mg capsules in quantities of 30 units. This competitive award, valued at $6,939.84, carries a firm fixed price and is scheduled for completion by September 30, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order, this award falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $3,919.30 to AmerisourceBergen Drug Corp for Carvedilol ER 10 mg capsules (30-count units) on September 17, 2025, with an ultimate completion date of September 18, 2025. This firm fixed price, competitively awarded contract represents a non-set-aside procurement and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Carvedilol ER 10 mg capsules (30-count units) with a ceiling value of $3,309.42 under firm fixed price terms. The order is scheduled for completion by September 19, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This is a non-set-aside competitive award issued as a child order under AmerisourceBergen's larger indefinite...
- The Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on September 26, 2025, for carvedilol ER 10 mg capsules (30-count) valued at $19,150.83. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 29, 2025. The delivery order supports pharmaceutical supply to federal medical procurement needs, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This award...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,255.74 for Carvedilol ER 20 mg capsules (30-count) with an ultimate completion date of August 28, 2025. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,556.63 for Carvedilol ER 40 mg capsules (30-count units) on September 15, 2025, with an ultimate completion date of September 16, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and specifies performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- SPE2DB24D2013Indefinite Delivery Contract
- SPE2DB24D2013-SPE2DB26FCGPQDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $9,529.47 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 80 mg capsules (30-count units), with an ultimate completion date of October 20, 2025. This is a firm fixed price, non-set-aside contract awarded on October 17, 2025, with performance to take place at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, holds a significant indefinite delivery contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, under which this delivery order is issued. As a subsidiary delivery order under the broader DLA pharmaceutical supply vehicle, this award reflects the agency's ongoing procurement of essential medications to support military and veteran healthcare systems. AmerisourceBergen's position as a primary pharmaceutical vendor for the Defense Logistics Agency demonstrates the company's capability to meet federal medical supply requirements through competitive procurement processes. The carvedilol supply supports cardiovascular treatment needs across the federal healthcare enterprise, leveraging the contractor's extensive portfolio of brand-name and generic medications across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.5k | 10/17/25 |